Search Results - carlo+tocchetti

1 Results Sort By:
P75 Neurotrophin Receptor Antagonist for the Treatment of Acute and Chronic Cardiac Disease
Unmet Need / Invention Novelty: Hemodynamic stress during heart disease results in adverse remodeling and loss of function of the myocardial  tissue. One mechanism that underlies this pathology is activation of the p75 neurotrophin receptors (p75NTR) in the heart. There is an unmet need for a therapeutic which blocks the p75 neurotrophin receptor in...
Published: 3/13/2025   |   Inventor(s): Nazareno Paolocci, Ning Feng, Carlo Tocchetti, Cyrus Takahashi, Bruce Carter
Keywords(s): Antagonists/Inhibitors, Biologics, Cardiovascular Diseases, Disease Indication, Myocardial Infarction (MI), Non-novel, Peptide, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Peptides, Clinical and Disease Specializations > Cardiovascular > Acute Heart Failure
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum